Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.
Patients should have faster access to newly developed drugs and medicines and the Government is prepared to adopt new ...
The US contributed approximately 42pc of global humanitarian aid in 2024, with the EU and Germany accounting for around 8pc ...
DelveInsight's Advanced Therapy Medicinal Products Market Insights report provides the current and forecast market analysis, ...
Hosted on MSN19h
EMA approves Takeda’s Takhzyro pre-filled pen option for HAEThe European Medicines Agency (EMA) has approved an additional 2 mL pre-filled pen option for subcutaneous administration of ...
The FDA and European Medicines Agency (EMA) mandate high similarity between biosimilars and reference products, but their ...
At this time, I would like to welcome everyone to Harmony Biosciences fourth quarter and full-year 2024 financial results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback